Dayun Bio-Medicine* - April 2026 Revenue: 172 Million (Year-on-Year Increase of +40.5%)

Key facts

  • Dayun Bio-Medicine* - April 2026 Revenue: 172 Million (Year-on-Year Increase of +40.5%)
  • Dayun Bio-Medicine* announced April 2026 revenue of 171.84 million yuan, achieving a significant 40.5% increase year-on-year. This growth indicates strong market performance for its food industry products.
  • Source: PR Times
  • Date: April 1, 2026

Direct answer

Dayun Bio-Medicine* announced April 2026 revenue of 171.84 million yuan, achieving a significant 40.5% increase year-on-year. This growth indicates strong market performance for its food industry products.

Citation
Dayun Bio-Medicine* - April 2026 Revenue: 172 Million (Year-on-Year Increase of +40.5%) (April 1, 2026), PR Times
Source
PR Times
Date
April 1, 2026
Dayun Bio-Medicine* announced April 2026 revenue of 171.84 million yuan, achieving a significant 40.5% increase year-on-year. This growth indicates strong market performance for its food industry products.
その他NQ 0/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: April 1, 2026 at 09:00
  • 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
  • 🤖 AI Analyzed: May 12, 2026 at 08:05 (5 min after Collected)
Company Code: 7780
Company Name: Dayun Bio-Medicine*
Industry: Food Industry
Data Month: 2026-04
Current Month Revenue: 171,837 thousand yuan (1.72 hundred million)
Year-on-Year Change: +40.5%

Keywords: Monthly Revenue, Food Industry

FAQ

What are the key facts in this article?

Dayun Bio-Medicine* announced April 2026 revenue of 171.84 million yuan, achieving a significant 40.5% increase year-on-year. This growth indicates strong market performance for its food industry products.

What is the direct answer?

Dayun Bio-Medicine* announced April 2026 revenue of 171.84 million yuan, achieving a significant 40.5% increase year-on-year. This growth indicates strong market performance for its food industry products.

What is the source and date?

PR Times: https://openapi.twse.com.tw/revenue/twse-rev-7780-11504 | April 1, 2026